X-Message-Number: 32767
Date: Sat, 14 Aug 2010 00:38:04 -0700 (PDT)
From: 
Subject: a proposal to stimulate cryonics research


Up till now funding for fully reversible organ cryopreservation (of which 
cryonics is an offshoot) has been limited. Cryoprotectant toxicity has been the 
primary roadblock to achieving this. However there are much less toxic 
alternatives to commonly used cryoprotectants. Unfortunately there is virtually 
no possibility for commercial applications using these superior cryoprotective 
agents because they are too expensive. I submit that nothing succeeds better 
than success in stimulating further funding. By pulling out all the stops, 
expense be damned, and actually using these less toxic but pricey cryoprotective
agents such as ectoin, DESO, and KF7G; fully reversible liquid nitrogen 
cryopreservation of entire animals is IMHO quite possible right now. Even 
cheating a bit, and using a naturally freeze tolerant animal, would not much 
reduce the impact of such a success. Seeing on national television even a frog 
or snake surviving storage in liquid nitrogen would massively stimulate further 
funding. With such an initial success then money would "suddenly" become 
available to research ways and means to reduce the toxicity of affordible 
cryoprotectants so that fully reversible organ cryopreservation (and even human 
suspended animation) becomes a commercial reality in the near, as opposed to the
distant future. There is one Canadian billionaire signed up for cryonics, but 
who is otherwise not active in funding research, and there are as yet no 
American billionaires that are interested. All this could change once the 
concept has been proven to work. Even Bill Gates might take notice.

Int J Artif Organs. 2010 Jun;33(6):370-80.

Alternatives to dimethylsulfoxide for serum-free cryopreservation of human 
mesenchymal stem cells.

Grein TA, Freimark D, Weber C, Hudel K, Wallrapp C, Czermak P. University of 
Applied Sciences Giessen-Friedberg, Institute of Biopharmaceutical Technology, 
Giessen - Germany.
Abstract

    Human mesenchymal stem cells (hMSCs) have some favorable characteristics 
    like high plasticity, multilineage differentiation potential, and comparably
    easy handling in vitro, making them of interest for many clinical and 
    therapeutic approaches including cell therapy. For routine applications, 
    these cells have to be stored over a certain period of time without loss of 
    cell vitality and function. An easy way to preserve cells is to store them 
    at temperatures between -80 degrees C and -196 degrees C (liquid nitrogen). 
    To prevent cells from the damage caused by the cryopreservation process and 
    to achieve high cell recovery and vitality, cryoprotectants are used. 
    Typically dimethylsulfoxide, often in combination with serum, is used as a 
    cryoprotectant. However, for clinical approaches, the use of 
    dimethylsulfoxide and serum in patients is problematic for several reasons. 
    Therefore, the cryopreservation of human mesenchymal stem cells for cell 
    therapeutic applications without dimethylsulfoxide and serum demands 
    investigation. In this work, non-toxic alternatives to dimethylsulfoxide 
    such as glycerol or the compatible solutes, proline and ectoin, were 
    analyzed in a serum-free cryomedium with respect to their cryoprotective 
    properties. Different concentrations of the cryoprotectants (1-10% (w/v) 
    ectoin or proline, respectively, or 5-20% (v/v) glycerol) and certain 
    incubation times (0-60 minutes) were investigated with regard to post-thaw 
    cell vitality and cell growth. Our results showed that, in general, 
    cryopreservation with ectoin led to high post-thaw cell survival of up to 
    72% whereas after cryopreservation with glycerol and proline, the hMSC cells
    were completely dead (glycerol) or had only poor cell survival (proline, 
    22%). Moreover, the morphology of the hMSC cells changed to a large and flat
    phenotype after cryopreservation with proline. These results indicate that 
    glycerol and proline are not suitable for cryopreservation of hMSC. In 
    contrast, ectoin has the potential to replace dimethylsulfoxide as a 
    cryoprotectant in a serum-free cryomedium.
PMID: 20669142

Cryobiology. 2004 Aug;49(1):1-9.

Glass-forming property of the system diethyl sulphoxide/water and its 
cryoprotective action on Escherichia coli survival.

Markarian SA, Bonora S, Bagramyan KA, Arakelyan VB. Department of Chemistry, 
Yerevan State University, 375049 Yerevan, Armenia.
Abstract

    In this work the thermal properties of diethyl sulphoxide (Et2SO), as well 
    as its cryoprotective ability are studied and related to other well-known 
    cryoprotectant substances, like dimethyl sulphoxide (Me2SO). We have 
    investigated the thermal properties of Et2SO/water systems using 
    Differential Scanning Calorimetry at a very low heating/cooling rate (2 
    degrees C/min). Liquid/solid or glassy/crystalline transitions have been 
    observed only for the solutions with content of Et2SO ranging from 5 up to 
    40% w/w and/or greater than 85%. In the 45-75% w/w Et2SO range we have found
    a noticeable glass-forming tendency and a great stability of the amorphous 
    state to the reheating. In samples with Et2SO content ranging from 80 to 
    85%, we observed a great stability of the glass forming by cooling, but a 
    lesser stability to the subsequent reheating. The glass-forming tendency of 
    these solutions is discussed in terms of existing competitive interactions 
    between molecules of Et2SO, on the one hand, and Et2SO and water molecules, 
    on the other hand. The results are well explainable on the basis of the 
    model structure of water/Et2SO solutions, deduced by Raman and infrared 
    studies [J. Mol. Struct. 665 (2003) 285-292]. The cryoprotective ability of 
    Et2SO on Escherichia coli survival has been also investigated, and a 
    comparison among Et2SO and other widely used cryoprotectants, like Me2SO and
    glycerol has been done. Survival of E. coli, determined after 
    freezing-thawing process, was maximal at 45% w/w Et2SO (more than 85% 
    viability). It should be noted that at the same concentration the survival 
    is only about 35% in the presence of Me2SO and not more than 15% in the 
    presence of glycerol. These features are well consisted with the 
    glass-forming properties of Et2SO.
PMID: 15265712

Cryobiology. 2008 Dec;57(3):242-5. Epub 2008 Sep 15.

Improved cryopreservation by diluted vitrification solution with 
supercooling-facilitating flavonol glycoside.

Kami D, Kasuga J, Arakawa K, Fujikawa S. National Agricultural Research Center 
for Hokkaido Region, Sapporo 062-8555, Japan.
Abstract

    The effect of kaempferol-7-O-glucoside (KF7G), one of the 
    supercooling-facilitating flavonol glycosides which was originally found in 
    deep supercooling xylem parenchyma cells of the katsura tree and was found 
    to exhibit the highest level of supercooling-facilitating activity among 
    reported substances, was examined for successful cryopreservation by 
    vitrification procedures, with the aim of determining the possibility of 
    using diluted vitrification solution (VS) to reduce cryoprotectant toxicity 
    and also to inhibit nucleation at practical cooling and rewarming by the 
    effect of supplemental KF7G. Examination was performed using shoot apices of
    cranberry and plant vitrification solution 2 (PVS2) with dilution. 
    Vitrification procedures using the original concentration (100%) of PVS2 
    caused serious injury during treatment with PVS2 and resulted in no regrowth
    after cooling and rewarming (cryopreservation). Dilution of the 
    concentration of PVS2 to 75% or 50% (with the same proportions of 
    constituents) significantly reduced injury by PVS2 treatment, but regrowth 
    was poor after cryopreservation. It is thought that dilution of PVS2 reduced
    injury by cryoprotectant toxicity, but such dilution caused nucleation 
    during cooling and/or rewarming, resulting in poor survival. On the other 
    hand, addition of 0.5mg/ml (0.05% w/v) KF7G to the diluted PVS2 resulted in 
    significantly (p<0.05) higher regrowth rates after cryopreservation. It is 
    thought that addition of supercooling-facilitating KF7G induced 
    vitrification even in diluted PVS2 probably due to inhibition of ice 
    nucleation during cooling and rewarming and consequently resulted in higher 
    regrowth. The results of the present study indicate the possibility that 
    concentrations of routinely used VSs can be reduced by adding 
    supercooling-facilitating KF7G, by which more successful cryopreservation 
    might be achieved for a wide variety of biological materials.
PMID: 18824164

Am J Physiol. 1990 Mar;258(3 Pt 2):R559-68.

Life in a frozen state: adaptive strategies for natural freeze tolerance in 
amphibians and reptiles.

Storey KB. Institute of Biochemistry, Carleton University, Ottawa, Ontario, 
Canada.
Abstract

    Winter survival for various species of amphibians and reptiles that 
    hibernate on land depends on freeze tolerance, the ability to survive for 
    long periods of time with up to 65% of total body water as extracellular 
    ice. Freeze tolerance has been described for four species of frogs, one 
    salamander, and hatchlings of the painted turtle. A very limited tolerance 
    also occurs in garter snakes. Studies of freeze tolerance in vertebrates 
    have primarily focused on the wood frog Rana sylvatica and have assessed the
    regulation of cryoprotectant synthesis, cryoprotectant action in freezing 
    preservation of isolated cells and tissues, metabolism and energetics under 
    the ischemic conditions imposed by freezing, and the role of ice-nucleating 
    agents in blood. The adaptations that preserve life at subzero temperatures 
    for these animals illustrate the principles of vertebrate organ 
    cryopreservation and may have important applications in the development of 
    technology for the freezing preservation of transplantable human organs.
PMID: 2180324

Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=32767